Tafluprost
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08819 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary hereditary glaucoma | KG + DL |
| 2 | visceral calciphylaxis | KG + DL |
| 3 | tinea nigra | KG + DL |
| 4 | arterial thoracic outlet syndrome | KG + DL |
| 5 | venous thoracic outlet syndrome | KG + DL |
| 6 | angiodysplasia of stomach | KG + DL |
| 7 | idiopathic spontaneous coronary artery dissection | KG + DL |
| 8 | neurogenic thoracic outlet syndrome | KG + DL |
| 9 | vascular disease | KG + DL |
| 10 | lymphangiectasis | KG + DL |
| 11 | hemangioendothelioma | KG + DL |
| 12 | blue toe syndrome | KG + DL |
| 13 | arterial dissection-lentiginosis syndrome | KG + DL |
| 14 | atheroembolism of kidney | KG + DL |
| 15 | respiratory failure | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.